{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:36:24Z","timestamp":1790087784579,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T00:00:00Z","timestamp":1398384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.aprim.2013.12.015","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T17:15:45Z","timestamp":1396545345000},"page":"56-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Diagn\u00f3stico y tratamiento de la hipercolesterolemia familiar en Espa\u00f1a: documento de consenso"],"prefix":"10.1016","volume":"47","author":[{"given":"Pedro","family":"Mata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Gonzalez-Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Badim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"D\u00edaz-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidio","family":"Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Galve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Irigoyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Fuentes-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"P\u00e9rez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2013.12.015_bib0005","series-title":"The Metabolic and Molecular Basis of Inherited Disease (volume II)","first-page":"2863","article-title":"Familial hypercholesterolemia","author":"Goldstein","year":"2001"},{"key":"10.1016\/j.aprim.2013.12.015_bib0010","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","volume":"2","author":"Slack","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2013.12.015_bib0015","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: Prevalence. Coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aprim.2013.12.015_bib0020","series-title":"Familial Hypercholesterolaemia: Report of a WHO Consultation","author":"World Health Organization","year":"1997"},{"key":"10.1016\/j.aprim.2013.12.015_bib0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0025-7753(02)72428-7","article-title":"Heterozygous familial hypercholesterolemia in Spain. Description of 819 non related cases","volume":"118","author":"Alonso","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.aprim.2013.12.015_bib0030","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: A long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2013.12.015_bib0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2009.09.014","article-title":"Evaluation of cholesterol lowering treatment of patients with familial hipercholesterolemia: A large cross-sectional study in The Netherlands","volume":"209","author":"Pijlman","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0040","doi-asserted-by":"crossref","DOI":"10.1186\/1476-511X-10-94","article-title":"Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)","volume":"10","author":"Mata","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0045","unstructured":"National Health Medical Research Council (NHMRC). NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. Pilot program 2005-2007, 2005."},{"key":"10.1016\/j.aprim.2013.12.015_bib0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/qhc.12.1.18","article-title":"Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project","volume":"12","year":"2003","journal-title":"Qual Saf Health Care"},{"issue":"Suppl 3","key":"10.1016\/j.aprim.2013.12.015_bib0055","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2011.04.003","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.aprim.2013.12.015_bib0060","doi-asserted-by":"crossref","first-page":"a1095","DOI":"10.1136\/bmj.a1095","article-title":"Familial hypercholesterolemia: Summary of NICE guidance","volume":"337","author":"Wierzbicki","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2013.12.015_bib0065","unstructured":"World Health Organization. Familial Hypercholesterolemia: Report of a second WHO consultation, World Health Organisation, Human Genetics programme, Division of Non-communicable Diseases. World Health Organization, Geneva, Switzerland (1999) (WHO publication no. WHO7HGN\/FH\/CONS\/99.2)."},{"key":"10.1016\/j.aprim.2013.12.015_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.12.001","article-title":"The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population","volume":"180","author":"Damgaard","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0075","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjcard.2008.06.056","article-title":"Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia","volume":"102","author":"Civeira","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.aprim.2013.12.015_bib0080","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0021-9150(01)00533-0","article-title":"The use of Achilles tendon ultrasonography for the diagnosis of familial hypercholesterolemia","volume":"157","author":"Descamps","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.39300.616076.55","article-title":"Child-parent screening for familial hypercholesterolaemia: Screening strategy based on a meta-analysis","volume":"335","author":"Wald","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2013.12.015_bib0090","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2011.06.016","article-title":"Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization","volume":"218","author":"Descamps","year":"2011","journal-title":"Atherosclerosis"},{"issue":"Suppl 12","key":"10.1016\/j.aprim.2013.12.015_bib0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosissup.2011.06.001","article-title":"Familial hypercholesterolaemia: A model of care from Australasia","author":"Watts","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.anpedi.2009.02.005","article-title":"Hipercolesterolemia. Abordaje terap\u00e9utico","volume":"70","author":"Morais","year":"2009","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.aprim.2013.12.015_bib0105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment","volume":"223","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0110","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/humu.21258","article-title":"Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoproteinB in individuals with inherited hypercholesterolemia","volume":"31","author":"Huijgen","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.aprim.2013.12.015_bib0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2011.12.021","article-title":"Molecular characterization of familial hypercholesterolemia in Spain","volume":"221","author":"Palacios","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0120","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.aprim.2013.12.015_bib0125","doi-asserted-by":"crossref","first-page":"RRN1238","DOI":"10.1371\/currents.RRN1238","article-title":"Cascade screening for familial hypercholesterolemia (FH)","volume":"3","author":"Ned","year":"2011","journal-title":"PLoS Curr"},{"key":"10.1016\/j.aprim.2013.12.015_bib0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0300-8932(09)70021-1","article-title":"Cost-effectiveness analysis of a genetic screening program in the close relatives of Spanish patients with familial hypercholesterolemia","volume":"62","author":"Oliva","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2013.12.015_bib0135","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jacl.2010.08.022","article-title":"Defining the challenges of FH screening for familial hypercholesterolemia","volume":"4","author":"Defesche","year":"2010","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.aprim.2013.12.015_bib0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000111637","article-title":"Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening","volume":"11","author":"Leren","year":"2008","journal-title":"Community Genet"},{"issue":"Suppl 1","key":"10.1016\/j.aprim.2013.12.015_bib0145","first-page":"S1","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"271","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0150","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/archdischild-2011-300081","article-title":"Paediatric screening for hypercholesterolemia in Europe","volume":"97","author":"Kusters","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.aprim.2013.12.015_bib0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hyercholesterolemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2013.12.015_bib0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","article-title":"International panel on management of familial hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia","volume":"173","author":"Civeira","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2007.12.024","article-title":"Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors","volume":"200","author":"Alonso","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: Data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.aprim.2013.12.015_bib0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1586\/erc.13.7","article-title":"Early diagnosis and treatment of familial hypercholesterolemia: Improving patient outcomes","volume":"11","author":"Alonso","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.aprim.2013.12.015_bib0180","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2010.10.001","article-title":"Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia","volume":"213","author":"Miname","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0185","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(00)04053-8","article-title":"Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial","volume":"357","author":"Smilde","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2013.12.015_bib0190","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0021-9150(00)00733-4","article-title":"Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin","volume":"157","author":"Alonso","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2013.12.015_bib0195","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: A prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.aprim.2013.12.015_bib0200","first-page":"CD001918","article-title":"Dietary treatment for familial hypercholesterolemia","volume":"2","author":"Poustie","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2013.12.015_bib0205","first-page":"CD006401","article-title":"Statins for children with familial hypercholesterolemia","volume":"7","author":"Vuorio","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2013.12.015_bib0210","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MOL.0b013e3283402f53","article-title":"Severe hypercholesterolaemia: Therapeutic goals and eligibility criteria for LDL apheresis in Europe","volume":"21","author":"Thompson","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.aprim.2013.12.015_bib0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apher"},{"key":"10.1016\/j.aprim.2013.12.015_bib0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurpub\/cks174","article-title":"Quality of life in a cohort of familial hypercholesterolemia patients from the south of Europe","volume":"24","author":"Mata","year":"2014","journal-title":"Eur J Public Health"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656714000614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656714000614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:57:05Z","timestamp":1538701025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656714000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0212656714000614"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2013.12.015","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagn\u00f3stico y tratamiento de la hipercolesterolemia familiar en Espa\u00f1a: documento de consenso","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2013.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}